The Silent Skin Destroyer: Inside the Mystery of Buruli Ulcer
The Painless Disease That Destroys Skin: Why Buruli Ulcer Is One of Medicine's Biggest Mysteries
Imagine developing a massive, destructive ulcer on your arm or leg – and feeling absolutely no pain. No fever. No warning signs your body is fighting an infection. Just a painless lump that slowly transforms into an open wound the size of your hand.
This is Buruli ulcer, one of the strangest bacterial infections doctors have ever encountered. And here’s the unsettling part: after more than a century of study, scientists still don’t know how people catch it.
I became fascinated by this disease after reading WHO reports about communities in West Africa where children suddenly develop these mysterious ulcers. What I discovered is a medical detective story that stretches from Victorian Uganda to modern-day Australia, involving a bacterium that produces a toxin unlike anything else in nature.
The Disease Time Forgot
The first medical description of Buruli ulcer came from Sir Albert Cook in Uganda in 1897. But it wasn’t until the 1930s that Australian scientists, led by Peter MacCallum, finally managed to grow the responsible bacterium in a lab – using samples from patients in Bairnsdale, Australia.
The disease gets its name from Buruli County in Uganda, where an explosion of cases in the 1960s brought it to international attention. Since then, it’s been reported in 33 countries across Africa, the Americas, Asia, and the Western Pacific.
Here’s what makes it so strange: in Africa, about half of all patients are children under 15. But in Australia? The average patient is around 60 years old. Same disease, completely different age profiles. Nobody knows why.
A Toxin Like No Other
The culprit is Mycobacterium ulcerous, a cousin of the bacteria that cause tuberculosis and leprosy. But this one does something uniquely sinister.
It produces a toxin called mycobactin – and this is where things get really interesting from a scientific perspective. Mycobactin is an immunosuppressive toxin, meaning it shuts down your body’s local immune response. Your immune cells just… stop working in that area.
This is why Buruli ulcer doesn’t hurt. This is why there’s no fever, no inflammation, no signs of infection. The toxin literally prevents your body from mounting its normal defensive response. It’s like the bacterium cloaks itself in invisibility.
Dr. Françoise Portales, one of the leading researchers on Buruli ulcer, once told a journalist that mycobactin is “one of the most potent natural immunosuppressants ever discovered.” And unlike other bacterial toxins that kill cells quickly, mycobactin destroys tissue slowly, methodically, creating those characteristic large ulcers with white and yellow bases.
The Mystery No One Can Solve
Here’s the frustrating part for public health officials: we still don’t know how people get infected.
We know M. ulcerous is an environmental bacterium – it lives in nature, not in people. We’ve found it in water, in certain insects, even in possums in Australia. But the actual route of transmission? Complete mystery.
Some researchers think it might be through contaminated water. Others suspect insect bites – particularly water bugs. There’s evidence in Australia linking it to mosquitoes. Some cases seem to cluster around slow-moving or stagnant water bodies.
But here’s the thing: you can have two children playing in the same river, living in the same house, doing exactly the same activities – and only one develops Buruli ulcer. It’s maddeningly unpredictable.
This makes prevention nearly impossible. You can’t tell people “avoid X to prevent Buruli ulcer” when you don’t know what X is.
What It Looks Like
The disease typically starts as a painless nodule – just a firm lump under the skin, usually on the arms or legs, though it can appear anywhere. People often ignore it because it doesn’t hurt.
Over weeks or months, that nodule develops into an ulcer. The skin breaks down, creating an open wound. These ulcers can become enormous – I’ve seen photos of lesions covering entire limbs. And remember: still painless. Still no fever.
The white or yellow base of the ulcer is actually dead tissue – necrosis caused by the mycobactin toxin. If you look at it under a microscope, you can see the characteristic “ghost cells” – cells that look normal but are completely dead.
Left untreated, these ulcers can cause massive scarring, permanent disfigurement, and serious disability. People lose function in their limbs. Children can’t go to school. Adults can’t work. The social and economic impacts ripple through entire families and communities.
The Good News: We Can Cure It
Here’s the hopeful part of this story: if caught early, Buruli ulcer is completely curable with antibiotics.
The current WHO treatment protocol is straightforward: rifampicin (10 mg per kilogram of body weight daily) plus clarithromycin (7.5 mg per kilogram twice daily) for eight weeks.
That’s it. Two antibiotics, eight weeks, and in most cases, the ulcer heals completely.
The catch? You need to catch it early. Once the ulcer becomes large, you might need surgery to remove dead tissue and skin grafts to help healing. Some patients need physiotherapy to restore function. Psychological support helps people cope with visible scarring.
The real challenge isn’t the treatment – it’s getting people diagnosed before the ulcer becomes massive. And that brings us back to the painless problem. When something doesn’t hurt, people don’t seek medical care urgently.
Where It Happens
Buruli ulcer occurs mainly in tropical and subtropical regions, with a few notable exceptions like Australia, China, and Japan.
West Africa has been particularly hard hit. Countries like Benin, Côte d’Ivoire, and Ghana report hundreds of cases annually. I spoke with health workers there who described entire villages where multiple children have the characteristic scars.
In Australia, most cases cluster in specific regions of Victoria. Researchers have identified certain coastal areas and wetlands as hotspots. The Australian cases tend to be less severe than African ones, though nobody knows why.
Out of 33 affected countries, only 14 regularly report data to WHO. The actual global burden is probably much higher than official numbers suggest. Many cases in remote areas never get diagnosed or reported.
The Bigger Picture: Skin Neglected Tropical Diseases
WHO has started viewing Buruli ulcer as part of a larger category called “skin neglected tropical diseases” or skin NTDs. This group includes leprosy, yaws, leishmaniasis, and several other conditions.
Why group them together? Because they require similar healthcare responses: early detection, antibiotics or other medications, wound care, physiotherapy, psychological support, and long-term follow-up.
By integrating the approach to these diseases, health systems can be more efficient. Train health workers to recognize all skin NTDs, not just one. Establish wound care clinics that treat multiple conditions. Build rehabilitation services that serve all patients who need them.
It’s a smart strategy that WHO is promoting worldwide. Rather than having separate vertical programs for each disease, create integrated skin health services.
What Needs to Happen
The WHO established the Global Buruli Ulcer Initiative back in 1998, but progress has been slow. Here’s what experts say is needed:
Research into transmission. We desperately need to understand how people get infected. This is the key to prevention. Countries like Australia are doing sophisticated environmental studies trying to crack this mystery.
Earlier detection. Community education about recognizing nodules and seeking care immediately. Training frontline health workers to diagnose Buruli ulcer. Making diagnostic testing more available – PCR tests can confirm infection from a simple swab.
Better access to treatment. The antibiotics are relatively cheap, but they need to reach rural areas where most cases occur. Wound care supplies and trained personnel need to be available.
Integrated health services. Building permanent skin health clinics that can handle Buruli ulcer along with other skin NTDs. This creates sustainable systems rather than disease-specific programs.
Reduced stigma. People with visible scars face discrimination in many communities. Education and awareness campaigns can help reduce this.
Why You Should Care
You might be thinking: “I don’t live in Africa or Australia. Why does this matter to me?”
Here’s why: Buruli ulcer represents a broader challenge in global health. It’s a preventable, treatable disease that causes enormous suffering simply because affected communities lack resources and attention.
It’s also a scientific puzzle. Understanding how mycobactin works could teach us important things about immunology and wound healing. Solving the transmission mystery could reveal important principles about how environmental bacteria infect humans.
And there’s the basic human dimension. Children shouldn’t develop massive ulcers that scar them for life when simple antibiotics could cure them if caught early. The fact that this still happens – that we have the cure but can’t deliver it effectively – says something about global health priorities.
The diseases that get attention, funding, and research are usually those affecting wealthy countries. The ones that don’t – the “neglected” tropical diseases – continue causing preventable suffering in poor communities.
Buruli ulcer won’t make headlines. It doesn’t cause pandemics. But for the families affected, it’s devastating.
The good news is that solutions exist. We just need the will to implement them.
Frequently Asked Questions About Buruli Ulcer
Buruli ulcer is a chronic skin disease caused by the bacterium Mycobacterium ulcerous. It produces a toxin called mycobactin that destroys skin tissue, creating large, painless ulcers. It belongs to the same bacterial family as tuberculosis and leprosy.
The mycobactin toxin produced by the bacteria suppresses the local immune response, including the inflammatory signals that cause pain. This immunosuppressive property allows the disease to progress without pain, fever, or other typical signs of infection, making early detection difficult.
This is one of medicine’s biggest mysteries – we still don’t know for certain. The bacterium lives in the environment, possibly in water or associated with certain insects. Cases cluster near slow-moving water bodies, and some research suggests insect bites may be involved, but the exact transmission route remains unknown.
In Africa, about half of patients are children under 15 years old. In Australia, the average patient is around 60. The disease typically affects people living near wetlands, rivers, or slow-moving water in tropical and subtropical regions. Why different age groups are affected in different places is unclear.
It’s been reported in 33 countries across Africa, the Americas, Asia, and the Western Pacific. Most cases occur in West Africa (particularly Benin, Côte d’Ivoire, and Ghana) and certain regions of Australia. It mainly affects tropical and subtropical areas, with some exceptions.
For more information:
Disclaimer: This article is an adaptation of publicly available information from WHO’s Buruli Ulcer
health topic page (WHO, Geneva. Licence: CC BYNC-SA 3.0 IGO). WHO is not responsible for the
content or accuracy of this adaptation. This content is for informational and educational purposes
only and does not constitute medical advice. ObserverVoice.com is a news and information platform
— not a healthcare provider.
Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.
